Quay Pharma is now part of sgs logoopens in a new window
Contact Us  
Company Overview

INNOVATIVE FORMULATION DEVELOPMENT CDMO

Company Overview

INNOVATIVE FORMULATION DEVELOPMENT CDMO

We are a Contract Development Manufacturing Organisation (CDMO). We specialise in the development of innovative new entities for biotech companies, globally.

SGS Quay PharmaWatch Introduction
Contact Us  
Company Overview

INNOVATIVE FORMULATION DEVELOPMENT CDMO

Company Overview

INNOVATIVE FORMULATION DEVELOPMENT CDMO

We are a Contract Development Manufacturing Organisation (CDMO). We specialise in the development of innovative new entities for biotech companies, globally.

Company Overview

World Leading Pharmaceutical CDMO, Experts in Formulation Development.

Company Overview

Company Overview

Formulation Development Services

We create robust formulation development strategies tailored to the characteristics of each individual API. We complement the drug discovery process with clearly set-out costs for specific stages, totally transparent from the preclinical stage, formulation, dosage form development and optimisation.

View Our Services

Live Biotherapeutics Product Delivery

Experienced formulation development and licensed for the clinical manufacture of live biotherapeutics products for digestive, urogenital and pulmonary delivery. We can prepare a strategy to bring your dosage requirement rapidly and effectively to First in Human studies, and beyond.

See How We're Leading The Way

Your Drug Development Consultancy

SGS PACE (Product Accelerated Clinically Enabled) is a new unique, streamlined pathway from preclinical to First in Human/Proof of Concept. SGS PACE provides an expert-directed roadmap to clinic through one Program Manager who will work closely with you and always keep your objectives and goals in mind.

Discover SGS PACE

Put Your Project In The Hands of Quay Pharma

Quay Pharma is a contract development manufacturing organisation (CDMO). Since 2002, we have proudly delivered over 250 successful projects and exercised continued improvement whilst remaining true to our core values.

Our proven manufacturing technologies provide a low economic risk, fast entry into human trials, and elevated scale-up to future clinical phases.

We have knowledge and expertise in formulating and developing a wide range of product formats and dosage forms for modified and targeted release within the body.

We are licensed for the clinical and commercial manufacturing of new chemical entities, biologicals and live biotherapeutics in a non-sterile environment.

Our core strength is our people. We invest in the best and only experts with strong scientific backgrounds that underpins our service.

ASK OUR EXPERTS

Talk directly to the Quay staff - Our dedicated team leaders are ready to listen and help with your project.

Contact Us  
Meet Our Experts
Explore our list of experts, and find out more about their specialities.
Ask Our Experts
Ask a Question
Have a question? Contact an expert directly using our online forms.
Contact An Expert
FAQs
We have been compiling answers to many FAQs - browse our list.
View Our FAQs

NEWS & MEDIA

News Portal